Castle Biosciences to Participate in Upcoming Investor Conferences
2024年8月28日 - 8:00PM
ビジネスワイヤ(英語)
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving
health through innovative tests that guide patient care, today
announced that its executive management is scheduled to present a
company overview at Baird’s 2024 Global Healthcare Conference on
Wednesday, Sept. 11, 2024, at 9:05 a.m. Eastern time.
A live audio webcast of the Company’s presentation will be
available by visiting Castle Biosciences’ website at
ir.castlebiosciences.com/events-presentations/. A replay of the
webcast will be available following the conclusion of the live
broadcast.
Castle will also be available for one-on-one investor meetings
during the 8th Annual Lake Street Best Ideas Growth (BIG8)
Conference on Sept. 12, 2024. Meetings may be requested exclusively
through Lake Street Capital Markets.
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics
company improving health through innovative tests that guide
patient care. The Company aims to transform disease management by
keeping people first: patients, clinicians, employees and
investors.
Castle’s current portfolio consists of tests for skin cancers,
Barrett’s esophagus, mental health conditions and uveal melanoma.
Additionally, the Company has active research and development
programs for tests in other diseases with high clinical need,
including its test in development to help guide systemic therapy
selection for patients with moderate-to-severe atopic dermatitis,
psoriasis and related conditions. To learn more, please visit
www.CastleBiosciences.com and connect with us on LinkedIn,
Facebook, X and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, MyPath
Melanoma, DiffDx-Melanoma, TissueCypher, IDgenetix, DecisionDx-UM,
DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle
Biosciences, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240828537095/en/
Investor Contact: Camilla Zuckero
czuckero@castlebiosciences.com
Media Contact: Allison Marshall
amarshall@castlebiosciences.com
Castle Biosciences (NASDAQ:CSTL)
過去 株価チャート
から 9 2024 まで 10 2024
Castle Biosciences (NASDAQ:CSTL)
過去 株価チャート
から 10 2023 まで 10 2024